skip to primary navigationskip to content
 

Entrepreneurship

Carpe Diem Christopher R Lowe Enterprise awards

The Department exemplifies that new opportunities arise when under-pinning disciplines are assembled in a single organisation and allied with a strong entrepreneurial ethos. Our  focus  on the exploitation of research provides a seamless transition from the laboratory to commercial development and the market-place. Through these activities Chemical Engineering and Biotechnology at Cambridge have contributed significantly to the ‘Cambridge Phenomenon’.

The Department has 15 spin-out companies in the 2013 Cambridge Enterprise portfolio. Collectively, they have raised substantial City, Angel and VC funding and currently employ >600 people, although, with one exception (ProMetic BioSciences; market capitalisation ~$950M), they remain privately owned. The entrepreneurial culture was recognised by a Queen’s Anniversary Prize in 2007.

Life science entrepreneurship is further supported in the department and throughout the University by the Christopher R. Lowe Enterprise Awards Programme.  Annually, this generous initiative provides tuition bursaries for Master's in Bioscience Enterprise postgraduate students, seed funds and mentors promising life science companies selected by Cambridge University Entrepreneurs(CUE), sponsors the Cambridge University Technology and Enterprise Club's conference (CUTEC) and recognises the University's 'Young Life Science Entrepreneur of the Year'. 

The Department also benefits from the wider advisory, legal and financial support services of the University, through the active engagement of the Research Office and Cambridge Enterprise and through these office our staff are incentivised  to file patents by an IP revenue-sharing scheme.

Incubation

A key development planned for the future is to incorporate a number of independent small company incubator units within our state-of-the-art building (opening 2015) to improve the Department’s commercialisation strategy even further. The spin-out pipeline will be promulgated through normal university channels, including Cambridge Enterprise, but without pre-mortgaging intellectual property. Cambridge Enterprise Ltd plays a key role in helping the Department’s researchers in commercialising their discoveries – supporting them in obtaining patents and licences and assisting in setting up companies to develop ideas further and launch products on the open market. 

RSS Feed Latest news

Machine learning predicts mechanical properties of porous materials

May 16, 2019

Machine learning can be used to predict the properties of a group of materials that, according to some, could be as important to the 21st century as plastics were to the 20th.

Alumna Fiona Erskine publishes “The Chemical Detective” book

May 10, 2019

Chemical Engineering alumna and writer Fiona Erskine publishes “The Chemical Detective”, a crime thriller with a chemical engineering protagonist.

New approach to drug discovery could lead to personalised treatment of neuropsychiatric disorders

May 09, 2019

Researchers from our Centre for Neuropsychiatric Research have developed a method that could drastically accelerate the search for new drugs to treat mental health disorders such as schizophrenia.

View all news

Upcoming events

CEB Research Conference 2019

Jun 25, 2019

Department of Chemical Engineering and Biotechnology, Philippa Fawcett Drive, Cambridge, CB3 0AS

Machine learning and AI in (bio)chemical engineering

Jul 08, 2019

Department of Chemical Engineering and Biotechnology, Philippa Fawcett Drive, Cambridge, CB3 0AS

Stokes200 Symposium

Sep 15, 2019

Pembroke College, Cambridge

VPF8 Viscoplastic Fluids: from Theory to Application 2019

Sep 16, 2019

Jesus College, Cambridge

Upcoming events